@article{df29e913fe1c45c0bc2aadf20d71bfd2,
title = "Lenalidomide plus melphalan without prednisone for previously untreated older patients with multiple myeloma: A phase II trial",
author = "White, {Darrell J.} and Bahlis, {Nizar J.} and Marcellus, {Deb C.} and Andrew Belch and Stewart, {A. Keith} and Christine Chen and Kovacs, {Michael J.} and MacDonald, {David A.} and Reece, {Donna E.} and Tony Reiman and Erica Harnett and Meyer, {Ralph M.} and Chapman, {Judy Anne W.} and Stephen Couban",
note = "Funding Information: Drs White, Bahlis, Chen, Macdonald, Reece, Reiman, and Meyer have received honoraria and research funding from Celgene Corporation. Dr Belch has received research funding from Celgene Corporation. Dr Stewart has received honoraria from Celgene Corporation. All other authors have stated that they have no conflicts of interest. Funding Information: This work was supported by a grant to the NCIC CTG from the Canadian Cancer Society Research Institute (grant 21,039 ). Lenalidomide was provided by Celgene Corporation (Summit, NJ). ",
year = "2013",
month = feb,
doi = "10.1016/j.clml.2012.08.009",
language = "English",
volume = "13",
pages = "19--24",
journal = "Clinical Lymphoma, Myeloma and Leukemia",
issn = "2152-2650",
publisher = "Cancer Media Group",
number = "1",
}
